OptiNose Files Definitive Proxy Statement
| Field | Detail |
|---|---|
| Company | Optinose, Inc. |
| Form Type | DEFA14A |
| Filed Date | Mar 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, regulatory-filing, pharmaceutical
TL;DR
OptiNose filed its proxy statement, shareholders vote soon.
AI Summary
OptiNose, Inc. filed a DEFA14A on March 20, 2025, reporting on events up to March 19, 2025. The filing is a definitive proxy statement, indicating it relates to a shareholder meeting or vote. The company, incorporated in Delaware, is in the pharmaceutical preparations industry and is headquartered in Yardley, Pennsylvania.
Why It Matters
This filing is a standard regulatory document that provides shareholders with information regarding upcoming votes or meetings, which could impact corporate governance and future company decisions.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEFA14A) and does not contain new financial information or strategic changes that would inherently increase risk.
Key Players & Entities
- OptiNose, Inc. (company) — Filer of the DEFA14A
- 0001494650-25-000049 (dollar_amount) — Accession Number for the filing
- March 19, 2025 (date) — Date of earliest event reported
- March 20, 2025 (date) — Filing date
- Yardley, Pennsylvania (location) — Company headquarters
FAQ
What is the purpose of a DEFA14A filing?
A DEFA14A filing is a definitive proxy statement used to solicit shareholder votes on specific matters, such as director elections or corporate actions.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on March 19, 2025.
What is OptiNose, Inc.'s primary industry?
OptiNose, Inc. is in the Pharmaceutical Preparations industry, with SIC code 2834.
Where is OptiNose, Inc. headquartered?
OptiNose, Inc. is headquartered at 777 Township Line Road, Suite 300, Yardley, Pennsylvania 19067.
What is the SEC file number for OptiNose, Inc.?
The SEC file number for OptiNose, Inc. is 001-38241.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on March 20, 2025 regarding OptiNose, Inc..